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ABSTRACT One of the useful properties of probiotic bacteria is their capacity to bind different targets, thus eliminating
them through feces. It is supposed that one of these targets could be cadmium, a widespread environmental toxicant that
causes various disturbances in biological systems. This study examined the protective effects of probiotic supplementation
against cadmium-induced toxicity in the rat. The experiment was conducted in the course of 5 weeks. Animals were divided
into four groups: (1) controls, (2) probiotics treated, (3) cadmium treated, and (4) probiotics + cadmium treated. The cadmium
concentration was measured in the blood, liver, kidney, and feces, as well as the blood alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) as biomarkers of the liver function. Histomorphological changes in the liver and kidney
were also determined. Our results revealed that probiotics combined with cadmium increase this metal concentration in feces.
As a result, blood, liver, and kidney Cd levels, as well as blood ALT and AST activities were lessened compared to the rat
group treated with cadmium only. Besides, probiotics consumed simultaneously with cadmium attenuated histomorphological
changes in the liver and kidney caused by cadmium. The rise in lactobacilli number in feces of rats treated simultaneously
with cadmium and probiotics results in strong correlation with the increase of Cd concentration in their feces and the decrease
of Cd concentration in their blood. We speculate that probiotics actively contribute to cadmium excretion through feces,
probably, by its binding to their bacterial cell wall.
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INTRODUCTION
Cadmium is a toxic metal and one of the most commonenvironmental hazards found in agricultural and in-
dustrial areas,1 especially in the atmosphere.2 Humans are
mostly exposed to cadmium through the intake of contami-
nated air, food, and water, or inhalation of tobacco smoke.3
Extreme cadmium toxicity for mammals has been verified
in many experimental models4 and its harmfulness to hu-
mans in accidental toxicity is also well known.5 Cadmium is
toxic to almost every organ in the body, with the liver and
kidneys as main targets.6 In the liver, it causes various
histological changes, including damage to hepatic paren-
chyma and increased infiltration of inflammatory cells.7
These disturbances lead to elevation of plasma alanine
aminotransferase (ALT), aspartate aminotransferase (AST),
lactate dehydrogenase, and alkaline phosphatase.7,8
One of the useful properties of probiotic bacteria is their
capacity to adhere to different targets.9–11 For example,
some probiotic strains, such as Lactobacillus rhamnosusGG
(ATCC 53103) and L. rhamnosus LC-705 (DSM 7061), may
remove aflatoxin B from aqueous solution,10 as well as
mutagen pollutants from foodstuffs.11 Also, Bifidobacterium
longum 46, L. fermentum ME3, and B. lactis Bb12 bind to
cadmium and lead in the water.9
However, all those studies were conducted in vitro. How-
ever, recently, the Cd binding capacity of probiotics was also
demonstrated in vivo12: only cadmium given orally could be
removed through feces, but not that injected intraperitoneally.13
The results of our trial examining whether probiotics may
exert similar effects in rats are presented in this study. We
have selected rat as a model given that study results can be
better translated to humans since it is widely believed that rats
are physiologically more similar to humans than mice.14
Besides, rat model is believed to be superior to mouse models
for the study of toxicity, because of similarity in the number
and type of detoxifying enzymes to those in humans.15
MATERIALS AND METHODS
Animals and treatments
This study was carried out in strict accordance with the
recommendations of Animal Welfare Act of Serbia. The
Manuscript received 8 June 2016. Revision accepted 7 November 2016.
Address correspondence to: Sinisa Djurasevic, PhD, Faculty of Biology, University of
Belgrade, Studentski trg 3, Belgrade 11000, Serbia, E-mail: sine@bio.bg.ac.rs
JOURNAL OF MEDICINAL FOOD
J Med Food 00 (0) 2016, 1–8
# Mary Ann Liebert, Inc., and Korean Society of Food Science and Nutrition
DOI: 10.1089/jmf.2016.0090
1
protocols were approved by the Committee on the Ethics of
Animal Experiments of the University of Belgrade, Faculty
of Biology.
Male rats of Wistar strain (Rattus norvegicus), weighing
130 – 10 g, were used for the experiments. The animals were
acclimated to 22C – 2C, exposed to a 12-h light/12-h dark
regime with the light on at 6 a.m. and off at 6 p.m., with free
access to commercial rat food (Veterinary Institute, Sub-
otica, Serbia) and tap water. Rats were randomly divided
into four groups, each consisting of six animals. Animals
were individually housed, with cages randomly distributed
on shelves close to each other to allow social interactions
among animals. Animals were treated as follows:
Control group: rats given tap water to drink ad libitum and
fed with commercial food;
Probiotic group: rats given tap water to drink ad libitum
and fed with commercial food supplemented with probiotic
bacteria (commercial preparation PROBIOTIC; Ivancic´ i
sinovi d.o.o.). The capsules were declared to contain 5 · 109
lyophilized cells of Lactobacillus rhamnosus Rosell-11,
Lactobacillus acidophilus Rosell-52, and Bifidobacterium
longum Rosell-175 strains. However, after identifying the
number of bacteria present in the capsules, we found that the
number of viable cells was around 5 · 108. One capsule was
mixed with one gram of food to achieve a final probiotic
concentration of 5 · 108 cfu/g food. Based on the rat food
consumption during 5 weeks, the total probiotic supple-
mentation was on average around 7.5· 109 cfu/100 g body
mass/day;
Cadmium group: rats given cadmium chloride (CdCl2,
analytical grade; Fisher Scientific) in a volume concentra-
tion of 70 ppm in tap water to drink ad libitum and fed with
commercial food. Based on the rat water consumption
during 5 weeks, the total cadmium intake was on average
around 1.25mg of CdCl2/100 g body mass/day;
Probiotic + cadmium group: rats fed with probiotics and
given to drink CdCl2. Based on the rat food and water
consumption during 5 weeks, the total probiotic supple-
mentation was on average around 6.9· 109 cfu/100 g body
mass/day and 1.09mg of CdCl2/100 g body mass/day.
The experiment was conducted for 5 weeks. The animal
body mass and food and water consumption were measured
daily. At the end of the treatment, the feces were collected
and stored at -80C until analysis. Animals were decapi-
tated with a guillotine (Harward-Apparatus) without anes-
thesia. The blood, collected from the trunk, was divided into
two sets of tubes, with EDTA added to get plasma.
Biochemical analyses
Serum, plasma and feces were frozen at -80C for sub-
sequent determination of AST, ALT, and Cd concentrations.
ALT and AST were measured in serum by a Randox kit,
where the products of ALT and AST action (pyruvate and
oxaloacetate, respectively), in the presence of NADH, and
the enzymes lactate and malate dehydrogenase, respec-
tively, oxidize NADH to NAD. This reaction is followed by
a decrement in absorbance at 340 nm. ALT and AST ac-
tivities were calculated as U/L= 1746 ·DA(340nm/min), where
DA(340nm/min) is the mean absorbance decrease between the
first and second, and second and third minutes.
Cadmium was determined in the whole blood, liver, and
kidney of individual animals, as well as in feces collected
during the last week of the experiment. Before spectro-
photochemical determination of the Cd concentration, the
samples were digested with 1mL of H2O2 and 7mL of
concentrated HNO3. Digestion was performed according to
the US EPA SW-846 Method 3052 with a Milestone
ETHOS One microwave digestion system at 200C. The
feces digests were filtered to remove undestroyed silicate
salts, although the procedure extracts the total bioavailable
cadmium amount. The metal concentration was determined
according to the US EPA SW-846 7000B method for
flame atomic absorption spectroscopy analysis with a
FIG. 1. Water consumption (mL/day/100 g
of body weight) of controls, and rats treated
with probiotics, cadmium, or their combina-
tion, over a period of treatment (5 weeks),
presented as mean – SEM.
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Varian, SpectraAA atomic absorption spectrophotometer.
A Merck 1000mg/L cadmium solution was used for the
standard curve.
Histopathological analysis
Samples of the left kidney (sagittal sectioned halves) and
liver (left lobe) were removed, thoroughly rinsed in ice-cold
physiological saline (0.9% NaCl), and fixed in 10% neutral-
buffered formalin (AnalaR NORMAPUR; VWR). After
dehydration in a rising series of ethanol solutions (50%,
70%, 95%, 100%), tissue samples were cleared in xylene
and set in paraffin. Five-micrometer-thick tissue sections
were subjected to the periodic acid-Schiff reaction using
a commercial detection kit (Bio Optica). Specimens were
photographed using a Leica DMLB light microscope and the
histological structure was examined.
Statistical analysis and graphic presentation
Data were evaluated by two-way analysis of variance
(ANOVA) and the Spearman Rank-Order correlation using
SigmaStat (Version 3.10) software. Holm–Sidak compari-
sons were performed when ANOVAwas significant. Results
are presented as mean –SEM of six animals using P < .05 as
the minimum level of significance.
RESULTS
Animals from each experimental group consumed very
similar amounts of water and food throughout the experi-
ment (Figs. 1 and 2). During the same period, a 45% de-
crease was found in the body weight gain in the group of
animals treated with cadmium, compared to the controls
(Fig. 3). In contrast, no decrease in the body weight gain was
present either in the group of animals treated with probiotics
or in that given probiotics + cadmium.
Exposure of animals to CdCl2 increased cadmium con-
centration in both the blood and feces, compared with the
control group of animals (Fig. 4). Adding probiotics to
cadmium increased feces Cd concentration, but decreased
blood Cd concentration compared to the CdCl2-treated
group.
Alterations in the liver and kidney cadmium accumula-
tion show that administration of CdCl2 increases this metal
concentration in both tissues (Fig. 5). However, it should be
noted that the maximum Cd accumulation in the liver is
twice as high as that in the kidney. When animals were
treated with probiotics and cadmium simultaneously, both
liver and kidney Cd contents decreased significantly in re-
spect to the group treated with cadmium only.
FIG. 2. Food consumption (g/day/100 g of
body weight) of controls, and rats treated with
probiotics, cadmium, or their combination,
over a period of treatment (5 weeks), pre-
sented as mean –SEM.
FIG. 3. Body weight gain (g/5 weeks/100 g of body weight) of
controls, and rats treated with probiotics, cadmium, or their combi-
nation, over a period of treatment (5 weeks), presented as mean–
SEM. An asterisk above the bars marks a significant difference
against control group of animals, whereas an asterisk inside the bars
indicates a significant difference between cadmium-treated versus
probiotic + cadmium-treated group of animals.
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As regard to the activity of liver enzymes, administration
of cadmium chloride alone resulted in an increased activity
of serum ALT and AST in comparison to both control and
probiotic-treated animals (Fig. 6). At the same time, pro-
biotics in combination with CdCl2 significantly decreased
both ALT and AST cadmium-induced increase.
The liver and kidney, as main target organs of cadmium
accumulation, were subjected to histomorphological analy-
sis (Figs. 7 and 8 respectively, light microscopy, magnifi-
cation 100· ). Organs taken from control rats (Figs. 7A and
8A), as well from those that consumed probiotics (Figs. 7B
and 8B), had normal macroscopic appearance without any
sign of injury.
In CdCl2-treated rats, liver sinusoids, especially those which
are closer to the central vein, became enlarged (Fig. 7C).
Kupffer cells were activated, with many cytoplasmic protru-
sions at the surface and residual bodies inside the cell (inset of
Fig. 7C). Clusters of hepatocytes containing large, irregularly
shaped, poorly delineated intracytoplasmic vacuoles and small
pyknotic nucleus were scattered throughout the parenchyma. In
these areas, the structureofhepatic cordswasblurred.Small foci
of hepatocytes in different stages of cell death were also seen in
some sites. It should be noted that despite rich vascularization of
the liver, there was almost no bleeding during isolation and
prefixation procedures.
In the kidney, renal corpuscles and proximal tubular ep-
ithelium showed clear signs of injury after CdCl2 treatment
(Fig. 8C). Proximal nephrocytes were typically vacuolated,
with nucleus displaced from the cell center, while brush
border was occasionally degenerated (Fig. 8C left). Des-
quamated dead nephrocytes and nephrocyte nuclei might be
seen inside the tubular lumen. Sporadic occurrence of tu-
bular necrosis was also noted. Glomeruli showed gradual
signs of injury, from hypercellularity, capillary enlarge-
ment, and ‘‘tuft segmentation’’ to glomerular shrinkage and
widening of urinary space (Fig. 8C right).
However, probiotics consumed simultaneously with
CdCl2 extenuated described changes in both organs
examined, although they remained obvious (Figs. 7D
and 8D).
The Spearman Rank-Order correlation among feces lac-
tobacilli number and feces and blood Cd concentration in
cadmium- and cadmium + probiotic-treated rats is shown in
Figure 9. We combined multiple results obtained from the
same experiment: previously published data on lactobacilli
number in feces,16 with the current data on the cadmium
concentration in blood and feces (Fig. 4). The rise in lac-
tobacilli number in feces of rats treated simultaneously with
cadmium and probiotic results is in strong positive corre-
lation with the increase of Cd concentration in their feces
(r = 0.769 and P = .00228). The increase of Cd concentration
in feces leads to the decrease of Cd concentration in blood
(r =-0.783 and P = .00139).
FIG. 4. Cadmium concentration (ppm)
in the feces and blood of controls, and rats
treated with probiotics, cadmium, or their
combination, presented as mean – SEM. An
asterisk above the bars marks a significant
difference against control group of animals,
whereas an asterisk inside the bars indicates
a significant difference between cadmium-
treated versus probiotic + cadmium-treated
group of animals.
FIG. 5. Cadmium concentration (ppm) in the liver and kidneys of
controls, and rats treated with probiotics, cadmium, or their combi-
nation, presented as mean –SEM. An asterisk above the bars marks a
significant difference against control group of animals, whereas an
asterisk inside the bars indicates a significant difference between
cadmium-treated versus probiotic + cadmium-treated group of animals.
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DISCUSSION
Administration of cadmium or probiotics (alone or in
combination) did not influence either water or food con-
sumption over the period of treatment (Figs. 1 and 2). Ac-
cordingly, it was intriguing to find out that cadmium
decreased the body weight gain in animals treated with
CdCl2 only (Fig. 3). The same has already been reported for
various species,17–21 suggesting that Cd could affect en-
zymes involved in glycogenesis, causing depletion of liver
and muscular glycogen and changes in the energetic me-
tabolism.17,22
The most of orally given cadmium is excreted through
feces,23 while the absorbed part is transported through
blood, with 50–70% of its accumulation in the kidneys and
liver.24 This is probably due to these organs’ high concen-
tration of metallothionein, which is known to bind a wide
range of metals, including cadmium.25
FIG. 6. Serum ALT and AST activity (U/L)
in controls, and rats treated with probiotics,
cadmium, or their combination, presented
as mean – SEM. An asterisk above the bars
marks a significant difference against control
group of animals, whereas an asterisk inside
the bars indicates a significant difference be-
tween cadmium-treated versus probiotic +
cadmium-treated group of animals. ALT,
alanine aminotransferase; AST, aspartate
aminotransferase.
FIG. 7. Light microscopy of the liver of
control (A), probiotic-treated (B), cadmium-
treated (C), and cadmium + probiotic-treated
rats (D). Arrow on (A) shows resting Kupffer
cell. Inset on (C) shows activated Kupffer
cells. Magnification 100·, Bar 20 lm.
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In line with above-mentioned studies, our results show
that in rats administered with cadmium, its concentration is
markedly elevated in the blood, feces, liver, and kidney
(Figs. 4 and 5). In contrast, the exposure of rats to the
combination of probiotics and cadmium increases Cd con-
tent in the feces, but decreases it in the blood, liver, and
kidneys (Figs. 4 and 5). Our results suggest that probiotics
accelerate cadmium elimination through feces, which cau-
ses an accompanying fall of its accumulation in blood
and tissues.
Administration of cadmium causes a significant elevation
in AST and ALT activity (Fig. 6). These findings are in line
with previously published reports, which indicated that all
these parameters were increased during cadmium toxici-
ty.6,8,13 Both ALT and AST are synthesized by the hepatic
cells and have been widely used as indicators of liver
function. When the hepatocytes are damaged (as we con-
firmed by histomorphological analyses), these enzymes are
released into the extracellular fluid, which results in the
rise of their activity in circulation.26 However, probiotic
FIG. 8. Light microscopy of the kidney of
control (A), probiotic-treated (B), cadmium-
treated (C), and cadmium + probiotic-treated
rats (D). On (C) (left) are shown proximal
nephrocyte vacuolation and necrosis. On (C)
(right) are shown shrunken glomerulus with
enlarged capillaries and reduction of cells.
Magnification 100 · , Bar 20 lm.
FIG. 9. The scatter matrix of Spearman Rank-Order correlation among feces lactobacilli number and cadmium concentration in feces and blood
of cadmium-treated and probiotic + cadmium-treated rats.
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supplementation together with the cadmium diminishes the
cadmium-induced rise in AST and ALT (Fig. 6).
Histopathological analyses show that Cd alone provokes
serious lesions in both the liver and kidneys (Figs. 7C and
8C). Patterns of these changes are typical for cadmium
toxicity and were previously reported and explained by
many authors.5,13,27–32 In general, liver injury is based
mainly on initial endothelial and hepatocellular damage,
which lead to activation of Kupffer cells and further in-
flammatory response. In the kidneys, tubular damage pre-
cedes progressive and irreversible glomerular changes and
may explain renal impairment. However, coadministration
of probiotics with cadmium leads to a considerable decrease
of described changes, including necrosis (Figs. 7D and 8D).
As we showed previously, exposure to Cd leads to the
significant decrease in lactobacilli counts in the feces, while
adding probiotics to cadmium causes their subsequent in-
crease.16 By combining those data with these data on the
cadmium concentration in blood and feces (Fig. 4), we
found strong correlations between feces lactobacilli increase
and feces Cd concentration increase and blood Cd concen-
tration decrease (Fig. 9).
We speculate that probiotics actively contribute to cad-
mium elimination through feces probably by binding it to
their bacterial cell wall. The surface of lactic acid bacteria
comprised a thick layer of peptidoglycan, teichoic acid,
proteins, and polysaccharides. All these structures contain
different kinds of negatively charged groups, like carboxyl,
hydroxyl, and phosphate groups, which are able to bind
cations such as cadmium.9,33
In conclusion, our results showed protective effects of
probiotics in cadmium-exposed animals, which leads open
the possibility of their therapeutic applications when oral
cadmium toxicity is involved.
ACKNOWLEDGMENTS
This work was supported by the Serbian Ministry of
Education, Science and Technological Development [pro-
ject nos. 173023, 176006].
AUTHOR DISCLOSURE STATEMENT
We wish to confirm that the material in the article has not
been, nor will be, submitted or published elsewhere and
there are no known conflicts of interest associated with this
publication.
We confirm that the article has been read and approved by
all named authors and that there are no other persons who
satisfied the criteria for authorship, but are not listed. We
further confirm that all of us have approved the order of
authors listed in the article.
We further confirm that any aspect of the work covered in
this article that has involved experimental animals has been
conducted with the ethical approval of all relevant bodies
and such approvals are acknowledged within the article.
We understand that the Corresponding Author is the sole
contact for the Editorial process (including Editorial Man-
ager and direct communications with the office). He is re-
sponsible for communicating with the other authors about
progress, submissions of revisions, and final approval of proofs.
REFERENCES
1. Satarug S, Baker JR, Urbenjapol S, et al.: A global perspective
on cadmium pollution and toxicity in non-occupationally ex-
posed population. Toxicol Lett 2003;137:65–83.
2. Cook CM, Sgardelis SP, Pantis JD, Lanaras T: Concentrations of
Pb, Zn, and Cu in Taraxacum spp. in relation to urban pollution.
Bull Environ Contam Toxicol 1994;53:204–210.
3. Nawrot T, Plusquin M, Hogervorst J, et al.: Environmental ex-
posure to cadmium and risk of cancer: A prospective population-
based study. Lancet Oncol 2006;7:119–126.
4. Waalkes MP: Cadmium carcinogenesis. Mutat Res 2003;533:
107–120.
5. Jarup L: Hazards of heavy metal contamination. Br Med Bull
2003;68:167–182.
6. Kowalczyk E, Kopff A, Fijalkowski P, et al.: Effect of antho-
cyanins on selected biochemical parameters in rats exposed to
cadmium. Acta Biochim Pol 2003;50:543–548.
7. Renugadevi J, Prabu SM: Cadmium-induced hepatotoxicity in
rats and the protective effect of naringenin. Exp Toxicol Pathol
2010;62:171–181.
8. Al-Hashem F, Dallak M, Bashir N, et al.: Camel’s Milk Protects
Against Cadmium Chloride Induced Toxicity in White Albino
Rats. Am J Pharmacol Toxicol 2009;4:107–117.
9. Halttunen T, Salminen S, Tahvonen R: Rapid removal of lead
and cadmium from water by specific lactic acid bacteria. Int J
Food Microbiol 2007;114:30–35.
10. Haskard CA, El-Nezami HS, Kankaanpaa PE, Salminen S,
Ahokas JT: Surface binding of aflatoxin B(1) by lactic acid
bacteria. Appl Environ Microbiol 2001;67:3086–3091.
11. Turbic A, Ahokas JT, Haskard CA: Selective in vitro binding of
dietary mutagens, individually or in combination, by lactic acid
bacteria. Food Addit Contam 2002;19:144–152.
12. Zhai Q, Wang G, Zhao J, et al.: Protective effects of Lactoba-
cillus plantarum CCFM8610 against acute cadmium toxicity in
mice. Appl Environ Microbiol 2013;79:1508–1515.
13. Zhai Q, Wang G, Zhao J, et al.: Protective effects of Lactoba-
cillus plantarum CCFM8610 against chronic cadmium toxicity in
mice indicate routes of protection besides intestinal sequestra-
tion. Appl Environ Microbiol 2014;80:4063–4071.
14. Abbott A: Laboratory animals: The Renaissance rat. Nature
2004;428:464–466.
15. Lindblad-Toh K: Genome sequencing: Three’s company. Nature
2004;428:475–476.
16. Jama A, Mitic-Culafic D, Kolarevic S, Durasevic S, Knezevic-
Vukcevic J: Protective effect of probiotic bacteria against
cadmium-induced genotoxicity in rat hepatocytes in vivo and in
vitro. Arch Biol Sci Belgrade 2012;64:1197–1206.
17. Sant’Ana MG, Moraes R, Bernardi MM: Toxicity of cadmium in
Japanese quail: Evaluation of body weight, hepatic and renal func-
tion, and cellular immune response. Environ Res 2005;99:273–277.
18. Erdogan Z, Erdogan S, Celik S, Unlu A: Effects of ascorbic acid
on cadmium-induced oxidative stress and performance of broil-
ers. Biol Trace Elem Res 2005;104:19–32.
19. Han XY, Xu ZR, Wang YZ, Huang QC: Effect of cadmium on
lipid peroxidation and activities of antioxidant enzymes in
growing pigs. Biol Trace Elem Res 2006;110:251–263.
PROBIOTICS AND CADMIUM TOXICITY 7
20. Rencuzogullari N, Erdogan S: Oral administration of lycopene
reverses cadmium-suppressed body weight loss and lipid per-
oxidation in rats. Biol Trace Elem Res 2007;118:175–183.
21. Martynowicz H, Skoczynska A, Wojakowska A, Turczyn B:
Serum vasoactive agents in rats poisoned with cadmium. Int J
Occup Med Environ Health 2004;17:479–485.
22. Toury R, Boissonneau E, Stelly N, Dupuis Y, Berville A, Perasso
R: Mitochondria alterations in Cd2+-treated rats: General re-
gression of inner membrane cristae and electron transport im-
pairment. Biol Cell 1985;55:71–85.
23. Satarug S, Garrett SH, Sens MA, Sens DA: Cadmium, environ-
mental exposure, and health outcomes. Environ Health Perspect
2010;118:182–190.
24. Andersen O, Nielsen JB, Svendsen P: Oral cadmium chloride
intoxication in mice: Effects of dose on tissue damage, intestinal
absorption and relative organ distribution. Toxicology 1988;48:
225–236.
25. Freisinger E, Vasak M: Cadmium in metallothioneins. Met Ions
Life Sci 2013;11:339–371.
26. Johnson PJ: Role of the standard ’liver function tests’ in current
clinical practice. Ann Clin Biochem 1989;26 (Pt 6):463–471.
27. Kuester RK, Waalkes MP, Goering PL, Fisher BL, McCuskey
RS, Sipes IG: Differential hepatotoxicity induced by cadmium
in Fischer 344 and Sprague-Dawley rats. Toxicol Sci 2002;65:
151–159.
28. Nolan CV, Shaikh ZA: The vascular endothelium as a target
tissue in acute cadmium toxicity. Life Sci 1986;39:1403–1409.
29. Prozialeck WC, Edwards JR, Woods JM: The vascular endothe-
lium as a target of cadmium toxicity. Life Sci 2006;79:1493–1506.
30. Rikans LE, Yamano T: Mechanisms of cadmium-mediated acute
hepatotoxicity. J Biochem Mol Toxicol 2000;14:110–117.
31. Barrouillet MP, Potier M, Cambar J: Cadmium nephrotoxicity
assessed in isolated rat glomeruli and cultured mesangial cells:
Evidence for contraction of glomerular cells. Exp Nephrol 1999;
7:251–258.
32. Jarup L, Akesson A: Current status of cadmium as an envi-
ronmental health problem. Toxicol Appl Pharmacol 2009;238:
201–208.
33. Halttunen T, Collado MC, El-Nezami H, Meriluoto J, Salminen
S: Combining strains of lactic acid bacteria may reduce their
toxin and heavy metal removal efficiency from aqueous solution.
Lett Appl Microbiol 2008;46:160–165.
8 DJURASEVIC ET AL.
